Danielle Burkhalter - 31 Jan 2023 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Human Resources Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
31 Jan 2023
Net transactions value
+$635,415
Form type
4
Filing time
06 Mar 2023, 16:53:44 UTC
Previous filing
06 Mar 2023
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Award $39,982 +740 +5.9% $54.03 13,233 31 Jan 2023 Direct F1
transaction SGRY Common Stock Sale $4,167 -123 -0.93% $33.88 13,110 13 Feb 2023 Direct F2
transaction SGRY Common Stock Sale $25,397 -757 -5.8% $33.55 12,353 31 Jan 2023 Direct F3
transaction SGRY Common Stock Award $499,998 +15,216 +123% $32.86 27,569 02 Mar 2023 Direct F4
transaction SGRY Common Stock Award $124,999 +3,804 +14% $32.86 31,373 02 Mar 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued based on 2022 performance under performance stock unit awards granted to the Reporting Person on March 11, 2022. Shares will vest in two equal annual installments on each of the first two anniversaries of January 31, 2023.
F2 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 10, 2023.
F3 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2023.
F4 Shares will all vest on the third anniversary of March 2, 2023.
F5 Shares will vest in three equal annual installments of each of the first three anniversaries of March 2, 2023.